Quarterly report · Q2
4465.TEDINET S100SLRA
Period2023-06-01 → 2023-11-30
Filed2024-01-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.2bn | 2023-06-01 → 2023-11-30 | Cons. | Net sales |
| Revenue | ¥19.5bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.5bn | 2022-06-01 → 2022-11-30 | Cons. | Net sales |
| Operating income | ¥629m | 2023-06-01 → 2023-11-30 | Cons. | Operating income |
| Operating income | ¥605m | 2022-06-01 → 2022-11-30 | Cons. | Operating income |
| Ordinary income | ¥623m | 2023-06-01 → 2023-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥887m | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥616m | 2022-06-01 → 2022-11-30 | Cons. | Ordinary income |
| Profit before tax | −¥55m | 2023-06-01 → 2023-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥617m | 2022-06-01 → 2022-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥118m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥562m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥396m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥122m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss |
| Net income | ¥396m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss |
| Total assets | ¥23.6bn | at 2023-11-30 | Cons. | Assets |
| Total assets | ¥23.6bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥21.7bn | at 2022-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.6bn | at 2023-11-30 | Cons. | Liabilities |
| Total liabilities | ¥10.6bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥13.0bn | at 2023-11-30 | Cons. | Net assets |
| Net assets / equity | ¥13.0bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥12.9bn | at 2022-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.9bn | at 2023-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.9bn | at 2023-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2023-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.4bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.1bn | at 2022-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥449m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥798m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥270m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥690m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥45m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥603m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥92m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥470m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥20.04 | 2023-06-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.46 | 2023-09-01 → 2023-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥95.13 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.13 | 2022-06-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.45 | 2022-09-01 → 2022-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 54.7% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.5% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 15
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥10.5bn |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥10.5bn |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥579m |
| jpcrp040300-q2r_E00890-000Healthcare Businessreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥693m |
| jpcrp040300-q2r_E00890-000Healthcare Businessreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥693m |
| jpcrp040300-q2r_E00890-000Healthcare Businessreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥50m |
| —segment total | revenue | 2023-06-01 → 2023-11-30 | ¥11.2bn |
| —segment total | revenue external | 2023-06-01 → 2023-11-30 | ¥11.2bn |
| —segment total | segment profit | 2023-06-01 → 2023-11-30 | ¥629m |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥9.5bn |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥9.5bn |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥605m |
| —segment total | revenue | 2022-06-01 → 2022-11-30 | ¥9.5bn |
| —segment total | revenue external | 2022-06-01 → 2022-11-30 | ¥9.5bn |
| —segment total | segment profit | 2022-06-01 → 2022-11-30 | ¥605m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 489
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 9537353000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 9537353000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00890-000ChemicalBusinessReportableSegmentsMember | 605270000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 605270000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1YTDDuration | 605270000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00890-000ChemicalBusinessReportableSegmentsMember | 10534760000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00890-000HealthcareBusinessReportableSegmentsMember | 693239000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 11228000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 11228000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00890-000ChemicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00890-000ChemicalBusinessReportableSegmentsMember | 10534760000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00890-000HealthcareBusinessReportableSegmentsMember | 693239000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 11228000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYTDDuration | 11228000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E00890-000ChemicalBusinessReportableSegmentsMember | 578906000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E00890-000HealthcareBusinessReportableSegmentsMember | 49977000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 628883000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | CurrentYTDDuration | 628883000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-01-12 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第62期第２四半期（自 2023年９月１日 至 2023年11月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社ニイタカ | |
| Company name in english cover page | FilingDateInstant | Niitaka Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 社長執行役員 野尻 大介 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)大阪市淀川区新高一丁目８番10号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | ０６(６３９１)３２６６ | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)執行役員 管理本部長 加藤 貴志 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)大阪市淀川区新高一丁目８番10号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | ０６(６３９１)３２６６ | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)執行役員 管理本部長 加藤 貴志 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00890 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 44650 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社ニイタカ | |
| Filer name in english | FilingDateInstant | Niitaka Co., Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |